DANIELLE PRESLEY: Open Payments
NPI 1518665892 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,651 in 271 payments from 41 companies in 2025. Trend: 2023 $2,478 · 2024 $4,792 · 2025 $5,651
Food & beverage: $5,578Education: $73
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $871 |
| ABBVIE INC. | 28 | $500 |
| ARGENX US, INC. | 20 | $340 |
| PFIZER INC. | 18 | $304 |
| Neurocrine BioSciences, Inc. | 29 | $297 |
| UCB, Inc. | 8 | $260 |
| CATALYST PHARMACEUTICALS, INC. | 8 | $248 |
| Biogen, Inc. | 9 | $218 |
| Teva Pharmaceuticals USA, Inc. | 11 | $202 |
| Celgene Corporation | 11 | $182 |
Products named: PONVORY, INGREZZA, FYCOMPA, NURTEC ODT, VYVGART, TYSABRI, ZEPOSIA, QULIPTA.
Industry payments across IN — which companies pay providers there.
